Quality control method of ginkgolide medicinal preparation

A quality control method and ginkgolide technology are applied in the field of quality control of ginkgolide pharmaceutical preparations

Active Publication Date: 2010-02-17
JIANGSU KANION PHARMA CO LTD
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, there is no quality control method for simultaneously measuring ginkgolide A, ginkgolide B, and ginkgolide K in ginkgolide pharmaceutical preparations. The present invention proposes a method that can effectively control the quality of ginkgolide injection, including After adjusting the pH of the injection to be acidic and acidified so that the lactones are all converted into lactones, the method of simultaneousl...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Quality control method of ginkgolide medicinal preparation
  • Quality control method of ginkgolide medicinal preparation
  • Quality control method of ginkgolide medicinal preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0175]Embodiment 1: a kind of quality control method of ginkgolide injection, the method comprises the steps:

[0176] High performance liquid chromatography content determination:

[0177] Determination according to high performance liquid chromatography (Appendix VID of Chinese Pharmacopoeia 2005 edition).

[0178] Chromatographic conditions and system suitability test: filler: silica gel bonded with octadecylsilane; mobile phase: isopropanol: methanol: water = 6:20:70; detection wavelength: 220nm; number of theoretical plates: according to ginkgo biloba Lactone B meter should not be less than 6000.

[0179] Preparation of reference substance solution: Take appropriate amount of reference substances of ginkgolide A, ginkgolide B, and ginkgolide K, weigh them accurately, add 50% acetone and dissolve them to make solutions containing 0.5mg, 0.5mg, and 0.1mg per 1 mL , that is.

[0180] Preparation of the test solution: Accurately measure 2ml of this product and put it in a ...

Embodiment 2

[0183] Embodiment 2: a kind of quality control method of ginkgolide injection, the method comprises the steps:

[0184] High performance liquid chromatography content determination:

[0185] Determination according to high performance liquid chromatography (Appendix VID of Chinese Pharmacopoeia 2005 edition).

[0186] Chromatographic conditions and system suitability test: filler: octadecylsilane bonded silica gel; mobile phase: isopropanol: methanol: water = 7:21:72; detection wavelength: 220nm; number of theoretical plates: according to Ginkgo Ester B meter should not be less than 7000.

[0187] Preparation of reference substance solution: Take appropriate amount of reference substances of ginkgolide A, ginkgolide B, and ginkgolide K, weigh them accurately, add 50% acetone and dissolve them to make solutions containing 0.5mg, 0.5mg, and 0.1mg per 1 mL , that is.

[0188] Preparation of the test solution: Accurately measure 2ml of this product and place it in a 10ml measur...

Embodiment 3

[0191] Embodiment 3: a kind of quality control method of ginkgolide injection, the method comprises the steps:

[0192] High performance liquid chromatography content determination:

[0193] Determination according to high performance liquid chromatography (Appendix VID of Chinese Pharmacopoeia 2005 edition).

[0194] Chromatographic conditions and system suitability test: filler: octadecylsilane bonded silica gel; mobile phase: isopropanol: methanol: water = 9:25:75; detection wavelength: 220nm; number of theoretical plates: according to Ginkgo biloba Ester B meter should not be less than 7000.

[0195] Preparation of reference substance solution: Take appropriate amount of reference substances of ginkgolide A, ginkgolide B, and ginkgolide K, weigh them accurately, add 50% acetone and dissolve them to make solutions containing 0.5mg, 0.5mg, and 0.1mg per 1 mL , that is.

[0196] Preparation of the test solution: Accurately measure 2ml of this product and place it in a 10ml...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a quality control method of medicinal preparation, in particular to a quality control method of ginkgolide medicinal preparation. The invention provides a method for controlling the quality of the ginkgolide medicinal preparation by adopting high performance liquid chromatography. The method can control the quality of the ginkgolide medicinal preparation by adopting one ormore of a content determination method, a limit test method of dissociation ginkgolide and a chromatographic fingerprint method. The quality control method provided by the invention has the advantages of having high precision, stability and repeatability, and achieving the aim of effectively controlling the quality of the ginkgolide medicinal preparation in an all-round way.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine analysis, and relates to a quality control method of traditional Chinese medicine preparations, in particular to a quality control method of ginkgolide pharmaceutical preparations. The quality control method includes a content determination method, a limit inspection method and a fingerprint spectrum determination method. technical background [0002] Ginkgolides are a group of terpenoids with strong biological activity contained in Ginkgo Leaf. The isolated ones include ginkgolides A, B, C, J, M, K, L and Bilobalides have been found to be strong antagonists of the vascular activating factor (PAF) and have good application prospects. BN52063 (Ginkgolide Mixture) and BN52021 (Ginkgolide B) have entered the clinical trial stage abroad. [0003] Ginkgolide pharmaceutical preparations are injections made from total ginkgolides, the main component of which is ginkgolide A (C 20 h 24 o 9 ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/16G01N30/36G01N30/86A61P9/10
Inventor 肖伟戴翔翎凌娅王振中毕宇安尚强邹艳萍章晨峰
Owner JIANGSU KANION PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products